Background The development of drug-resistant (DR) tuberculosis (TB) has become an
increasing concern over the past few decades as the result of numerous factors, including …

The WHO Consolidated Guidelines on Tuberculosis (TB), Module 4: Treatment-Drug-
Resistant Tuberculosis Treatment 2022 update informs health care professionals in Member …

Executive summary Tuberculosis (TB) strains with drug resistance (DR-TB) are more difficult
to treat than drug-susceptible ones, and threaten global progress towards the targets set by …

In order to support countries in their effort to respond to the challenges posed by the TB
epidemic over the years, WHO has produced and regularly updated guidelines for the …

Objective To assess the effectiveness of decentralized treatment and care for patients with
multidrug-resistant (MDR) tuberculosis, in comparison with centralized approaches …

Background In Ethiopia, MDR-TB has become a significant public health threat; therefore,
the Ministry of Health introduced two treatment approaches for MDR-TB cases: treatment …

Page 1 WHO consolidated guidelines on tuberculosis Module 4: Treatment Tuberculosis care and
support World Health Organization Page 2 WHO consolidat guidelines tuberculos Module Tubercu …

OBJECTIVE: To calculate the per-session and annual direct program costs to implement
directly observed therapy (DOT) for tuberculosis treatment and to conduct a cost attribution …

Abstract Background In India, multidrug-resistant tuberculosis (MDR-TB) patients are usually
treated in hospitals. Decentralised care model, however, has been suggested as a possible …

Background There is a need for easily accessible tuberculosis unit cost data, as well as an
understanding of the variability of methods used and reporting standards of that data …